The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
NK cells in HIV infection: Paradigm for protection or targets for ambush
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional diversity of helper T lymphocytes
Abbas, A. K., Murphy, K. M., & Sher, A. (1996) · Nature · doi:10.1038/383787a0 · Cited by 4,450
HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
Dragic, T., Litwin, V., Allaway, G. P., Martin, S. R., Huang, Y., Nagashima, K. A., Cayanan, C., Maddon, P. J., Koup, R. A., Moore, J. P., et al. (1996) · Nature · doi:10.1038/381667a0 · Cited by 3,174
The biology of human natural killer-cell subsets
Cooper, M. A., Fehniger, T. A., & Caligiuri, M. A. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02060-9 · Cited by 2,975
Biology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902
Lanier, L. L. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,769
CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1
Alkhatib, G., Combadiere, C., Broder, C. C., Feng, Y., Kennedy, P. E., Murphy, P. M., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5270.1955 · Cited by 2,706
The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates
Choe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P. D., Wu, L., Mackay, C. R., LaRosa, G., Newman, W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81313-6 · Cited by 2,287
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
Braud, V. M., Allan, D. S. J., O'Callaghan, C. A., Söderström, K., D'Andrea, A., Ogg, G. S., Lazetic, S., Young, N. T., Bell, J. I., Phillips, J. H., et al. (1998) · Nature · doi:10.1038/35869 · Cited by 2,227
Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
Kärre, K., Ljunggren, H. G., Piontek, G., & Kiessling, R. (1986) · Nature · doi:10.1038/319675a0 · Cited by 2,161
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R., & Moretta, L. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.197 · Cited by 1,778
Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset
Cooper, M. A., Fehniger, T. A., Turner, S. C., Chen, K. S., Ghaheri, B. A., Ghayur, T., Carson, W. E., & Caligiuri, M. A. (2001) · Blood · doi:10.1182/blood.v97.10.3146 · Cited by 1,449
CD107a as a functional marker for the identification of natural killer cell activity
Alter, G., Malenfant, J. M., & Altfeld, M. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.08.008 · Cited by 1,410
Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming
Martín-Fontecha, A., Thomsen, L. L., Brett, S., Gerard, C., Lipp, M., Lanzavecchia, A., & Sallusto, F. (2004) · Nature Immunology · doi:10.1038/ni1138 · Cited by 1,353
Direct Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell Receptors
Arase, H., Mocarski, E. S., Campbell, A. E., Hill, A. B., & Lanier, L. L. (2002) · Science · doi:10.1126/science.1070884 · Cited by 1,230
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS
Martin, M. P., Gao, X., Lee, J.-H., Nelson, G. W., Detels, R., Goedert, J. J., Buchbinder, S., Hoots, K., Vlahov, D., Trowsdale, J., et al. (2002) · Nature Genetics · doi:10.1038/ng934 · Cited by 1,189
Ferlazzo, G., Tsang, M. L., Moretta, L., Melioli, G., Steinman, R. M., & Münz, C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011149 · Cited by 994
Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells
Mandelboim, O., Lieberman, N., Lev, M., Paul, L., Arnon, T. I., Bushkin, Y., Davis, D. M., Strominger, J. L., Yewdell, J. W., & Porgador, A. (2001) · Nature · doi:10.1038/35059110 · Cited by 990
Colonna, M., Navarro, F., Bellón, T., Llano, M., García, P., Samaridis, J., Angman, L., Cella, M., & López-Botet, M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.11.1809 · Cited by 950
REGULATION OF IMMUNE RESPONSES THROUGH INHIBITORY RECEPTORS
Long, E. O. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.875 · Cited by 939
Natural killer cells, viruses and cancer
Cerwenka, A., & Lanier, L. L. (2001) · Nature Reviews Immunology · doi:10.1038/35095564 · Cited by 875
RECEPTORS FOR HLA CLASS-I MOLECULES IN HUMAN NATURAL KILLER CELLS
Moretta, A., Bottino, C., Vitale, M., Pende, D., Biassoni, R., Mingari, M. C., & Moretta, L. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.619 · Cited by 875
Cohen, G. B., Gandhi, R. T., Davis, D. M., Mandelboim, O., Chen, B. K., Strominger, J. L., & Baltimore, D. (1999) · Immunity · doi:10.1016/s1074-7613(00)80065-5 · Cited by 861
Recognition of a virus-encoded ligand by a natural killer cell activation receptor
Smith, H. R. C., Heusel, J. W., Mehta, I. K., Kim, S., Dorner, B. G., Naidenko, O. V., Iizuka, K., Furukawa, H., Beckman, D. L., Pingel, J. T., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092258599 · Cited by 767
A fresh look at tumor immunosurveillance and immunotherapy
Smyth, M. J., Godfrey, D. I., & Trapani, J. A. (2001) · Nature Immunology · doi:10.1038/86297 · Cited by 745
Natural killer cells and dendritic cells: rendezvous in abused tissues
Moretta, A. (2002) · Nature Reviews Immunology · doi:10.1038/nri956 · Cited by 704
Comparative studies of human FcRIII-positive and negative natural killer cells.
Nagler, A., Lanier, L. L., Cwirla, S., & Phillips, J. H. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.10.3183 · Cited by 696
Scharton, T. M., & Scott, P. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.2.567 · Cited by 608
Masur, P. B. H., Kaplan, J. E., & Holmes, K. K. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-5_part_2-200209031-00002 · Cited by 567
Close encounters of different kinds: Dendritic cells and NK cells take centre stage
Degli-Esposti, M. A., & Smyth, M. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1549 · Cited by 554
Mavilio, D., Lombardo, G., Benjamin, J., Kim, D., Follman, D., Marcenaro, E., O'Shea, M. A., Kinter, A., Kovacs, C., Moretta, A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409872102 · Cited by 544
Self-citationSpecific and nonspecific NK cell activation during virus infection
Dokun, A. O., Kim, S., Smith, H. R. C., Kang, H.-S. P., Chu, D. T., & Yokoyama, W. M. (2001) · Nature Immunology · doi:10.1038/ni714 · Cited by 477
Orange, J. S., Wang, B., Terhorst, C., & Biron, C. A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.4.1045 · Cited by 455
Sivori, S., Falco, M., Chiesa, M. D., Carlomagno, S., Vitale, M., Moretta, L., & Moretta, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403744101 · Cited by 455
Caligiuri, M. A., Zmuidzinas, A., Manley, T. J., Levine, H., Smith, K. A., & Ritz, J. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.5.1509 · Cited by 435
Cooper, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.10.012 · Cited by 434
Daniels, K. A., Devora, G., Lai, W. C., O'Donnell, C. L., Bennett, M., & Welsh, R. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.1.29 · Cited by 434
Vitale, M., Chiesa, M. D., Carlomagno, S., Pende, D., Aricò, M., Moretta, L., & Moretta, A. (2005) · Blood · doi:10.1182/blood-2004-10-4035 · Cited by 414
Interplay of natural killer cells and their receptors with the adaptive immune response
Raulet, D. H. (2004) · Nature Immunology · doi:10.1038/ni1114 · Cited by 413
Mavilio, D., Benjamin, J., Daucher, M., Lombardo, G., Kottilil, S., Planta, M. A., Marcenaro, E., Bottino, C., Moretta, L., Moretta, A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336091100 · Cited by 387
Self-citationNatural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis
Moretta, A., Biassoni, R., Bottino, C., Mingari, M. C., & Moretta, L. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01596-6 · Cited by 354
What is a natural killer cell?
Moretta, A., Bottino, C., Mingari, M. C., Biassoni, R., & Moretta, L. (2002) · Nature Immunology · doi:10.1038/ni0102-6 · Cited by 349
De Maria, A., Fogli, M., Costa, P., Murdaca, G., Puppo, F., Mavilio, D., Moretta, A., & Moretta, L. (2003) · European Journal of Immunology · doi:10.1002/eji.200324141 · Cited by 299
Self-citationOliva, A., Kinter, A. L., Vaccarezza, M., Rubbert, A., Catanzaro, A., Moir, S., Monaco, J., Ehler, L., Mizell, S., Jackson, R., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2323 · Cited by 291
Self-citationDendritic and Natural Killer Cells Cooperate in the Control/Switch of Innate Immunity
Zitvogel, L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20012040 · Cited by 268
Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity
Flores-Villanueva, P. O., Yunis, E. J., Delgado, J. C., Vittinghoff, E., Buchbinder, S., Leung, J. Y., Uglialoro, A. M., Clavijo, O. P., Rosenberg, E. S., Kalams, S. A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071548198 · Cited by 263
Chiesa, M. D., Vitale, M., Carlomagno, S., Ferlazzo, G., Moretta, L., & Moretta, A. (2003) · European Journal of Immunology · doi:10.1002/eji.200323986 · Cited by 258
Cellular ligands of activating NK receptors
Bottino, C., Castriconi, R., Moretta, L., & Moretta, A. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.02.007 · Cited by 255
Scott-Algara, D., Truong, L. X., Versmisse, P., David, A., Luong, T. T., Nguyen, N. V., Theodorou, I., Barré-Sinoussi, F., & Pancino, G. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.5663 · Cited by 238
Hu, P.-F., Hultin, L. E., Hultin, P., Hausner, M. A., Hirji, K., Jewett, A., Bonavida, B., Detels, R., & Giorgi, J. V. (1995) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199511000-00005 · Cited by 232
Falco, M., Biassoni, R., Bottino, C., Vitale, M., Sivori, S., Augugliaro, R., Moretta, L., & Moretta, A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.6.793 · Cited by 222
Fegan, C. (1997) · Molecular Pathology · doi:10.1136/mp.50.6.329-c · Cited by 190
Kottilil, S., Chun, T., Moir, S., Liu, S., McLaughlin, M., Hallahan, C. W., Maldarelli, F., Corey, L., & Fauci, A. S. (2003) · The Journal of Infectious Diseases · doi:10.1086/368222 · Cited by 177
Self-citationValentin, A., Rosati, M., Patenaude, D. J., Hatzakis, A., Kostrikis, L. G., Lazanas, M., Wyvill, K. M., Yarchoan, R., & Pavlakis, G. N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102672999 · Cited by 164
Defective natural immunity: an early manifestation of human immunodeficiency virus infection.
Ullum, H., Gøtzsche, P. C., Victor, J., Dickmeiss, E., Skinhøj, P., & Pedersen, B. K. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.3.789 · Cited by 160
Natural Killer Cells from HIV-1+ Patients Produce C-C Chemokines and Inhibit HIV-1 Infection
Fehniger, T. A., Herbein, G., Yu, H., Para, M. I., Bernstein, Z. P., O’Brien, W. A., & Caligiuri, M. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.6433 · Cited by 158
Bonaparte, M. I., & Barker, E. (2004) · Blood · doi:10.1182/blood-2004-02-0696 · Cited by 158
Ashkar, A. A., Bauer, S., Mitchell, W. J., Vieira, J., & Rosenthal, K. L. (2003) · Journal of Virology · doi:10.1128/jvi.77.16.8948-8956.2003 · Cited by 155
Bluman, E. M., Bartynski, K., Avalos, B. R., & Caligiuri, M. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118726 · Cited by 148
Tarazona, R., Casado, J. G., DelaRosa, O., Torre‐Cisneros, J., Villanueva, J. L., Sánchez, B., Galiani, M. D., Gonzalez, R., Solana, R., & Peña, J. (2002) · Journal of Clinical Immunology · doi:10.1023/a:1015476114409 · Cited by 123
Pathogen-induced private conversations between natural killer and dendritic cells
Chiesa, M. D., Sivori, S., Castriconi, R., Marcenaro, E., & Moretta, A. (2005) · Trends in Microbiology · doi:10.1016/j.tim.2005.01.006 · Cited by 89
Tasca, S., Tambussi, G., Nozza, S., Capiluppi, B., Zocchi, M. R., Soldini, L., Veglia, F., Poli, G., Lazzarin, A., & Fortis, C. (2003) · AIDS · doi:10.1097/00002030-200311070-00003 · Cited by 66
Lum, J. J., Schnepple, D. J., Nie, Z., Sanchez-Dardon, J. L., Mbisa, G. L., Mihowich, J., Hawley‐Foss, N., Narayan, S., Kim, J. E., Lynch, D. H., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.6033-6042.2004 · Cited by 65
Natural immunity and HIV disease progression.
Ullum, H., Cozzi-Lepri, A., Aladdin, H., Katzenstein, T., Victor, J., Phillips, A. N., Gerstoft, J., Skinhøj, P., & Pedersen, B. (1999) · AIDS (London) · doi:10.1097/00002030-199904010-00004 · Cited by 59
Ahmad, R., Sindhu, S. T. A. K., Tran, P., Toma, E., Morisset, R., Menézes, J., & Ahmad, A. (2001) · Journal of Medical Virology · doi:10.1002/jmv.2053 · Cited by 52
Azzoni, L., Rutstein, R. M., Chehimi, J., Farabaugh, M., Nowmos, A., & Montaner, L. J. (2005) · The Journal of Infectious Diseases · doi:10.1086/429300 · Cited by 52
Immune Function and Phenotype Before and After Highly Active Antiretroviral Therapy
Søndergaard, S. R., Aladdin, H., Ullum, H., Gerstoft, J., Skinh??j, P., & Pedersen, B. K. (2006) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/01.pas.0000213299.11649.103 · Cited by 45
Natural killer cell-mediated lysis of T cell lines chronically infected with HIV-1
BANDYOPADHYAY, S., Ziegner, U., CAMPBELL, D. E., Miller, D. S., Hoxie, J. A., & Starr, S. E. (1990) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1990.tb08107.x · Cited by 40
Gupta, N., Arthos, J. A., Khazanie, P., Steenbeke, T. D., Censoplano, N. M., Chung, E., Cruz, C. C., Chaikin, M. A., Daucher, M., Kottilil, S., et al. (2005) · Virology · doi:10.1016/j.virol.2004.12.018 · Cited by 39
Self-citationImmune Function and Phenotype Before and After Highly Active Antiretroviral Therapy
Søndergaard, S. R., Aladdin, H., Ullum, H., Gerstoft, J., Skinhøj, P., & Pedersen, B. K. (1999) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-199908150-00004 · Cited by 34
Fortis, C., Biswas, P., Soldini, L., Veglia, F., Careddu, A., Delfanti, F., Mantelli, B., Murone, M., Lazzarin, A., & Poli, G. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199911)29:11<3654::aid-immu3654>3.0.co;2-b · Cited by 16
Development of a whole blood staining device for use during Space Shuttle flights
Sams, C. F., Crucian, B. E., Clift, V. L., & Meinelt, E. M. (1999) · Cytometry · doi:10.1002/(sici)1097-0320(19990901)37:1<41::aid-cyto5>3.0.co;2-4 · Cited by 16
Cited by
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Björkström, N. K., Lindgren, T., Stoltz, M., Fauriat, C., Braun, M., Evander, M., Michaëlsson, J., Malmberg, K.-J., Klingström, J., Ahlm, C., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20100762 · Cited by 479
Pathogenic Mechanisms of HIV Disease
Moir, S., Chun, T.-W., & Fauci, A. S. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130254 · Cited by 463
Self-citationFriedman, S. L. (2008) · Toxicology · doi:10.1016/j.tox.2008.06.013 · Cited by 350
Lang, P. A., Lang, K. S., Xu, H. C., Grusdat, M., Parish, I. A., Recher, M., Elford, A. R., Dhanji, S., Shaabani, N., Tran, C. W., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118834109 · Cited by 311
Metadata
- Authors
- Fauci, A. S., Mavilio, D., & Kottilil, S.
- Venue
- Nature Reviews Immunology
- Published
- 2005-10-20
- Volume
- 5
- Issue
- 11
- Pages
- 835-843
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1999782096
- Cited by
- 306
- References
- 72
- FWCI
- 1.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.